Clinical Trial Update: Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Adbelimumab as adjuvant therapy for esophageal squamous cell carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adbelimumab

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Squamous Oesophageal Cancer | Phase 2 | Status: RECRUITING